1. Home
  2. TECX vs BOW Comparison

TECX vs BOW Comparison

Compare TECX & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$19.69

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

N/A

Current Price

$34.18

Market Cap

734.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
BOW
Founded
2019
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
734.3M
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
TECX
BOW
Price
$19.69
$34.18
Analyst Decision
Strong Buy
Hold
Analyst Count
10
7
Target Price
★ $71.00
$34.33
AVG Volume (30 Days)
182.1K
★ 205.1K
Earning Date
11-13-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 40.70
23.26
EPS
N/A
★ 0.96
Revenue
N/A
★ $551,589,000.00
Revenue This Year
N/A
$23.79
Revenue Next Year
N/A
$20.28
P/E Ratio
★ N/A
$35.66
Revenue Growth
N/A
★ 29.58
52 Week Low
$15.60
$21.21
52 Week High
$39.53
$35.07

Technical Indicators

Market Signals
Indicator
TECX
BOW
Relative Strength Index (RSI) 30.40 59.94
Support Level $16.77 $33.66
Resistance Level $22.44 $34.38
Average True Range (ATR) 1.08 0.19
MACD 0.16 -0.01
Stochastic Oscillator 4.51 31.88

Price Performance

Historical Comparison
TECX
BOW

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division, which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury, or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity, and hospitality segments, and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

Share on Social Networks: